NYMOX PHARMACEUTICAL CORPORATION Adjustments For Increase Decrease In Deferred Income
NYMOX PHARMACEUTICAL CORPORATION (NYMXF) reported Adjustments For Increase Decrease In Deferred Income of -$2.51 million for the 12-month period ending 2015-12-31, per its 20-F filed 2018-03-30.
Discontinued › Income Statement › Other Income
ifrs-full:AdjustmentsForIncreaseDecreaseInDeferredIncome · last filed 2018-03-30
| Period end | Adjustments For Increase Decrease In Deferred Income 12 month |
|---|---|
| 2015-12-31 | -$2.51M 20-F · filed 2018-03-30 |